Executive Summary
This one-day snapshot of 30 high-value federal grants (> $5M) totals $5.25B in obligations, with 21 bullish signals dominated by IT services and health administration contracts providing multi-year revenue visibility through 2026-2031. Public companies like Accenture ($791M HHS), Oracle ($423M VA), RTX/Raytheon ($119M GSA), Booz Allen ($109M GSA, up to $716M), and Maximus ($113M VA, $99M Treasury) capture significant stable funding amid full/open competition wins. Neutral signals cluster in NASA/Caltech space R&D ($1.2B+ across 6 awards to nonprofit), limiting equity upside; pervasive risks include high subawards (e.g., $156M in Peraton) and firm-fixed-price cost exposure.
Tracking the trend? Catch up on the prior High-Value Federal Grants ($5M+) digest from January 07, 2026.
Investment Signals(3)
- IT/Health Services Revenue Surge(HIGH)▲
21 contracts worth $3.8B+ obligated to IT firms (NAICS 541512/541519) for CMS/VA/IRS/State Dept, with 70%+ outlay progress signaling execution strength and options upside to $6B+.
- NASA R&D Locked to Nonprofits(HIGH)▲
6 Caltech awards total $1.2B+ obligations for space/earth science through 2028, fully committed but no public equity exposure as tax-exempt recipient.
- Small Biz IT Wins Scale Up(MEDIUM)▲
Small/SDVOSB firms like Minburn ($233M State), CivitasDX ($119M VA), G2 Ops ($119M GSA) secure $1B+ via set-asides/open comp, indicating growth path but private status limits direct access.
Risk Flags(3)
- Execution[HIGH RISK]▼
High subawards erode margins in 15+ contracts (e.g., $156M/100 subs in Peraton NOAA, $111M/8 in CivitasDX VA), creating subcontractor dependency.
- Execution[MEDIUM RISK]▼
Firm-fixed-price structures in 12 awards (e.g., Oracle $423M, Raytheon $119M) expose to cost overruns amid 4-9yr durations to 2029+.
- Market[MEDIUM RISK]▼
Long horizons to 2031 (e.g., Peraton, Booz Allen) vulnerable to FY2027+ budget shifts post-2026 election cycle.
Opportunities(3)
- ◆
$1.5B+ unexercised options across top awards (e.g., Booz Allen $607M, Minburn $348M, KBR $1.2B NASA) tied to 2026-2029 extensions.
- ◆
VA/HHS IT sustainment/DevSecOps demand (8 awards, $1.4B) favors incumbents like Oracle/Maximus for follow-ons beyond 2026 ends.
- ◆
SDVOSB/8(a) primes (e.g., CivitasDX, Dynamo Tech) with 80%+ outlay rates offer acquisition targets as revenue scales to $100M+.
Sector Themes(3)
- ◆
17/30 contracts ($2.7B) in NAICS 541512/541519 for CMS/VA/IRS/State, mostly cost-plus/FFP through 2026-2029, reflecting sustainment priority.
- ◆
HHS/VA awards total $1.7B (e.g., Accenture $791M FFE, First Coast $254M Medicare) with 75% avg outlays, signaling multi-year stability.
- ◆
Caltech captures $1.2B+ non-competed R&D to 2028, bypassing public equities.
Watch List(3)
- 👁
{"entity"=>"Booz Allen Hamilton", "reason"=>"$108M obligated GSA award with $716M ceiling through 2030 offers 6x upside in European ops.", "trigger"=>"Q1 FY26 option exercise >$200M"}
- 👁
{"entity"=>"KBR Wyle Services", "reason"=>"$53M NASA obligation with $1.29B potential in medical R&D starting 2025.", "trigger"=>"initial task orders/outlays in Q3 2025"}
- 👁
{"entity"=>"Peraton", "reason"=>"$208M NOAA LEO sustainment to 2031 with $263M options, but $156M subs flag margins.", "trigger"=>"subaward spend >70% of outlays"}
Get daily alerts with 3 investment signals, 3 risk alerts, 3 opportunities and full AI analysis of all 30 filings
🇺🇸 More from United States
View all →March 25, 2026
US Pre-Market SEC Filings Roundup — March 25, 2026
US Pre-Market SEC Filings Roundup
March 24, 2026
US Merger & Acquisition SEC Filings — March 24, 2026
US Merger & Acquisition SEC Filings
March 24, 2026
US Corporate Board Director Changes SEC Filings — March 24, 2026
US Corporate Board Director Changes SEC Filings
March 24, 2026
US Executive Officer Management Changes SEC — March 24, 2026
US Executive Officer Management Changes SEC